WP 1: Unique RD patients and phenotypes WP lead: Ana Rath INSERM-Orphanet, Paris, France Contributing partners: Charité Universitätsmedizin Berlin Centro Nacional de Análisis Genómico (CNAG-CRG) The Jackson Laboratory University of Tübingen WP1 addresses implementation steps 1-2.The ProjectWelcome The Project WP 1: Unique RD patients and phenotypes WP 2: Novel molecular causes WP 3: Changing patient lives: Translation to the clinic The Treatabolome WP 4: Bioinformatics and knowledge management WP 5: Engagement and impact Community Engagement Task Force WP 6: Coordination and innovation management WP 7: Ethics requirements The Group Consortium EKUT – 1a EKUT – 1b RUMC – 2 ULEIC – 3 UNEW – 4 MUH – 5 CHU Dijon – 6a UB – 6b CNAG-CRG – 7 EURORDIS – 8 INSERM-Orphanet – 9a INSERM-ICM – 9b INSERM-CRM – 9c CUP – 10 EMBL-EBI – 11 JAX – 12 KCL – 13 UCL-IoN – 14a UCL-ICH – 14b UA – 15 Uni Naples – 16 UNIFE – 17 UHB – 18 IPATIMUP – 19 UMCG – 20 Charité -21 SHU – 22 APHP – 23 Project Coordinator Project Office Steering Committee Scientific Advisory Board Independent Ethics Advisory Board Data Analysis Task Force (DATF) Data Interpretation Task Force (DITF) Associated European Reference Networks Collaborations Platforms & Tools Rare Diseases Models & Mechanisms For Clinicians For Model Organism Investigators Registry RDMM Committees Funded projects FAQ Results Scientific publications Deliverables & reports Other documents Meetings Next Meetings Past Meetings News
Ana Rath
Ana Rath